Production (Stage)
Sensei Biotherapeutics, Inc.
SNSE
$0.295
-$0.014-4.53%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -6.86M | -7.77M | -7.25M | -7.14M | -7.99M |
| Total Depreciation and Amortization | 34.00K | 331.00K | 332.00K | 328.00K | 331.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 595.00K | 1.40M | 848.00K | 937.00K | 1.47M |
| Change in Net Operating Assets | -859.00K | 250.00K | 603.00K | 85.00K | -1.43M |
| Cash from Operations | -7.09M | -5.79M | -5.47M | -5.79M | -7.62M |
| Capital Expenditure | -- | 0.00 | 0.00 | -109.00K | -37.00K |
| Sale of Property, Plant, and Equipment | 40.00K | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 7.15M | -3.15M | 12.91M | 7.02M | 5.81M |
| Cash from Investing | 7.19M | -3.15M | 12.91M | 6.91M | 5.77M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -211.00K | -207.00K | -204.00K | -201.00K | -199.00K |
| Issuance of Common Stock | -- | 13.00K | 0.00 | 21.00K | -- |
| Repurchase of Common Stock | -3.00K | 0.00 | 0.00 | 0.00 | -10.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -214.00K | -194.00K | -204.00K | -180.00K | -209.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -117.00K | -9.14M | 7.24M | 935.00K | -2.06M |